Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts.
about
T helper 17 cells promote cytotoxic T cell activation in tumor immunityOropharyngeal Candidiasis in HIV Infection: Analysis of Impaired Mucosal Immune Response to Candida albicans in Mice Expressing the HIV-1 TransgeneFunctional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitisFidelity of pathogen-specific CD4+ T cells to the Th1 lineage is controlled by exogenous cytokines, interferon-gamma expression, and pathogen lifestyle.Antifungal Tc17 cells are durable and stable, persisting as long-lasting vaccine memory without plasticity towards IFNγ cellsIRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?Th17 cells demonstrate stable cytokine production in a proallergic environmentLoss and dysregulation of Th17 cells during HIV infection.Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese diabetic mice.DRB1*0402 may influence arthritis by promoting naive CD4+ T-cell differentiation in to regulatory T cells.Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice.Th17 cells in cancer: help or hindrance?Development of a unique epigenetic signature during in vivo Th17 differentiation.Mechanisms controlling Th17 cytokine expression and host defenseT(H)17 cells in tumour immunity and immunotherapy.Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 productionDendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 SignalingRegulation and function of innate and adaptive interleukin-17-producing cellsPurinergic Signaling as a Regulator of Th17 Cell Plasticity.Mechanisms underlying antigen-specific tolerance of stable and convertible Th17 cells during suppression of autoimmune diabetes.Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset.Bcl6 expression specifies the T follicular helper cell program in vivo.The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms.T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.The polarization of immune cells in the tumour environment by TGFbeta.Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo.Up for Mischief? IL-17/Th17 in the tumour microenvironment.Adaptive immunity in the host-microbiota dialog.Cytokine reporter mice in immunological research: perspectives and lessons learned.Genetic controls of Th17 cell differentiation and plasticity.Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity.Inflammation and type one diabetes.Antigen-specific therapy against type 1 diabetes: mechanisms and perspectives.Sensitivity and resistance to regulation by IL-4 during Th17 maturation.STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and -independent mechanisms.Targeting Th17 cells in immune diseases.Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.Quantitative and functional profiles of CD4+ lymphocyte subsets in systemic lupus erythematosus patients with lymphopenia.Th17 and Th17-stimulated CD8⁺ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity.
P2860
Q24646584-90524E48-EE71-4168-8161-35640BABEE12Q27005798-28CB885A-E760-45D7-A541-DC070F102CD3Q27312222-17448A9D-4778-452C-AA51-DA25446BA033Q30496153-9B10AD74-F630-4382-B0CF-C1E1897564A3Q33757993-4817EF46-9E47-4043-ADB2-969C5C69D9A6Q34062484-0BA03231-383A-4FB6-B93C-947146C80BEDQ34146417-72DA5B6B-9D78-4F3B-8CC4-F6272B9F88A7Q34350569-39061BA5-3718-458B-A4AB-F0132F7D3951Q34488588-8BD17459-9808-4C7C-85D9-236A81439A53Q34516919-FCDB3FC1-43BC-459D-A825-AA56BDF2E369Q34519904-0B5A6F3C-4623-49C2-8665-51D170136363Q34913808-916598DE-C655-4D56-84B3-590E969930EBQ35089039-802BAF57-8318-4907-86E8-B4466F258262Q35096758-93777ED6-A2AF-4001-BC5D-578B7F4C39A6Q35623903-A37402B8-B876-4691-ADCD-3E1313081EE0Q35644280-8BFF6024-CD64-4673-A888-EA3F51A8DEADQ35674805-1C29000B-E20F-4090-8B3E-F387B9806332Q35731177-F449C341-3F65-4AF0-84E5-1DC3DCA4AE71Q36056842-417B16E4-604A-4484-93F7-E88962935DB2Q36109325-12A6B6FA-EF0B-4E12-8D65-67B2EC99BB52Q36219724-4B376867-EB57-41D3-8896-7B6EFF4B485CQ36277359-DCFC87DD-2C42-441D-9922-7F89D0041509Q36278036-14254002-5B03-4907-B652-4C5625021E70Q37377251-40326250-E3AD-402C-B91F-3C489617D009Q37423104-57A61299-DE75-4905-B815-2054CA2DBC14Q37454364-E8468CD1-D144-4CDB-B778-6D333E6C6D00Q37639995-E095D442-DFFC-476B-A2F4-9BFD5BFD7024Q37781690-112C7AFB-069A-4C1E-9534-B29DA1C358AAQ37800006-09037E41-FF7A-4C8C-836D-5A3A23229F57Q37808729-3FC02AC8-2C7B-4F42-A232-C296EDFF92DCQ37832615-FED79557-CD1B-43EB-881C-7AD2C52BC81AQ37883457-0ADF7FC5-61D7-4110-ABE9-33665BAE09B8Q37996976-2C6C5D36-E039-4682-9223-D6D910923BD1Q38184646-5A9F9B1D-9829-42C6-88EF-29C0EAB2DE06Q38771066-6E3CB45A-FAEF-4523-A275-D5388EC81371Q41720069-D8413F25-44C5-4CC1-AA68-2CA4E2A9658FQ41827404-AE2266E1-A9B2-42ED-A1C7-614C469F4EF6Q42251580-4A375A5E-0860-4D18-B888-8CCD7F9F2905Q44646641-3FB8498E-E08F-4E87-AA11-9ED24C3E1FC2Q44938649-E689CD3A-9A37-4950-8165-35A23A2A7EB6
P2860
Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cutting edge: in vitro generat ...... mal but not lymphopenic hosts.
@en
Cutting edge: in vitro generat ...... mal but not lymphopenic hosts.
@nl
type
label
Cutting edge: in vitro generat ...... mal but not lymphopenic hosts.
@en
Cutting edge: in vitro generat ...... mal but not lymphopenic hosts.
@nl
prefLabel
Cutting edge: in vitro generat ...... mal but not lymphopenic hosts.
@en
Cutting edge: in vitro generat ...... mal but not lymphopenic hosts.
@nl
P2093
P2860
P356
P1476
Cutting edge: in vitro generat ...... rmal but not lymphopenic hosts
@en
P2093
Roza Nurieva
Xuexian O Yang
P2860
P304
P356
10.4049/JIMMUNOL.0803931
P407
P577
2009-03-01T00:00:00Z